# A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata

> **NCT04445363** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Suzhou Zelgen Biopharmaceuticals Co.,Ltd** · enrollment: 160 (actual)

## Conditions studied

- Alopecia Areata(AA)

## Interventions

- **DRUG:** Jaktinib hydrochloride cream
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04445363
- **Lead sponsor:** Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-12
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04445363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04445363, "A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04445363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*